← Back to Search

Behavioural Intervention

Oculus Go VR headset for Gastroparesis

N/A
Waitlist Available
Led By Brian Lacy, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Summary

This trial is to see if VR therapy is a viable treatment method for gastroparesis, a condition where the stomach can't empty properly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient-reported adverse events
Secondary outcome measures
Change in Quality of life
Change in work productivity
Changes in abdominal pain
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active VR GroupExperimental Treatment1 Intervention
Subjects will be provided an Oculus Go VR headset pre-loaded with a "menu" of virtual reality programs which have been designed specifically to treat both acute and chronic pain. Subjects are required to use the VR headset at home four times daily, prior to breakfast, lunch, dinner, and bedtime. Each session will last approximately 15 minutes.
Group II: Sham VR GroupPlacebo Group1 Intervention
Subjects will be provided an Oculus Go VR headset pre-loaded two-dimensional nature video. Subjects are required to use the VR headset at home four times daily, prior to breakfast, lunch, dinner, and bedtime. Each session will last approximately 15 minutes.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,255 Previous Clinical Trials
3,835,376 Total Patients Enrolled
9 Trials studying Gastroparesis
597 Patients Enrolled for Gastroparesis
Brian Lacy, MDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
49 Total Patients Enrolled
~3 spots leftby Dec 2024